Potential Role of Pancreatic and Enteric Hormones in Regulating Bone Turnover
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
ADEQUATE NUTRIENT INTAKE and normal gastrointestinal function are essential to bone health. Disorders of nutrient supply caused by either abnormal intake (e.g., anorexia nervosa, starvation) or absorption (e.g., celiac disease, inflammatory bowel disease) may lead to bone disease and an increased fracture risk. (1) The majority of studies examining the effects of nutrients on bone turnover have focused on well-established nutrients (e.g., calcium and phosphate) and homeostatic regulators (e.g., PTH and vitamin D). Three recent observations have suggested the potential involvement of alternative mechanisms regulating the interaction between nutrition and bone turnover. First, bone turnover has a marked circadian rhythm (∼100%), with higher bone resorption at night. The mechanism regulating this rhythm seems to be partially related to the cyclical intake of nutrients. (2-4) Second, there is an acute suppression of bone resorption in vivo (∼50%), which occurs within hours of the ingestion of a mixed meal, glucose, protein, or calcium. (4-7) Third, in a rodent model, providing the normal diet in multiple small fractions decreased bone resorption measured using {3H}tetracycline excretion and increased BMD compared with a matched nutrient load given once a day. (8) These studies suggest acute changes in dietary intake or the pattern of nutrient intake may have an impact on bone homeostasis. This article reviews the evidence supporting an acute nutrient-induced regulation of bone homeostasis, discusses the potential mechanisms involved, and speculates on the possible evolutionary advantage this may confer on animals that have an intermittent supply (or intake) of nutrients. The importance of calcium in maintaining mineral homeostasis is well established. Increased physiological demands result in a reversible demineralization of the skeleton. The maintenance of calcium homeostasis is apparent during acute insufficiency (overnight fast), chronic insufficiency (malnutrition, starvation, anorexia nervosa), or transient increase in demand (e.g., lactation). During these periods, the skeleton acts as a reservoir from which there is rapid mobilization of mineral and buffer. Furthermore, during periods of acute excess (postprandial) or chronic excess (obesity, treatment of anorexia nervosa), mechanisms are in place to restore the balance. Short-term regulators are required to balance acute changes in supply and demand and act to minimize deviations from the set-point. In contrast, longer-term regulators may alter the set-point, resulting in a net increase (or decrease) in bone turnover. The acute nutrient-induced changes in bone turnover may represent the physiological adaptations of the organism to a variable energy and nutrient intake. Bone remodeling is a metabolically demanding process; therefore, mechanisms may exist to ensure that during times of energy (and nutrient) excess bone remodeling is balanced to favor bone formation (in excess of bone resorption), whereas during times of energy insufficiency, bone remodeling is balanced to favor bone resorption (in excess of bone formation) to maintain calcium homeostasis. It is possible that the mechanisms regulating the acute effects of feeding (postprandial) may well be different from (or in addition to) the mechanisms that come in to play during intermediate and long-term changes in nutrient intake (obesity). A similar effect may occur in the regulation of short- and long-term fasting. Similarly, the mechanisms that regulate feeding are likely to be different from those regulating fasting. One intriguing observation is the recent identification of a nutrient responsive signaling system involving SIRT1, which may be involved in energy homeostasis, diabetes, and life span. (9) One or more of the pancreatic or enteric hormones released during a normal physiological response to nutrient ingestion may potentially integrate nutrient intake and bone turnover. Several hormones involved in the postprandial response to nutrients have been shown to regulate bone turnover at pharmacological concentrations. However, the factor(s) regulating the acute postprandial decrease in bone resorption at physiological concentrations remain elusive. Recent studies have shown that a variety of nutrients, including ingestion of a mixed meal, (5) calcium, (10-14) glucose, (4, 6) or protein, (4) result in an acute suppression of bone turnover markers (Figs. 1 and 2). One study examined the effect of feeding a mixed meal to normal subjects and measured the change in serum markers (osteocalcin {OC}, procollagen type I N-terminal propeptide {PINP}, serum bone alkaline phosphatase {sbALP}, serum C-terminal telopeptide of type I collagen {sβCTX}, and serum N-terminal telopeptide of type I collagen {sNTX}) at 1 h and urine markers (urine immunoreactive free deoxypyridinoline {uifDPD}, urine N-terminal telopeptide of type I collagen {uNTX}, and urine C-terminal telopeptide of type I collagen {uCTX}) at 2
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Ho, K. Y., Veldhuis, J. D., Johnson, M. L., Furlanetto, R., Evans, W. S., Alberti, K. G., & Thorner, M. O. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113450 · Cited by 503 · cited 5×
“(49,74) During fasting, there is a marked increase in the nocturnal secretion of GH,(75,76) which is suppressed by feeding.”
BackgroundInfluentialLeptin directly regulates bone cell function in vitro and reduces bone fragility in vivo
Cornish, J., Callon, K., Bava, U., Lin, C., Naot, D., Hill, B., Grey, A., Broom, N., Myers, D., Nicholson, G., et al. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750405 · Cited by 472
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
Hoff, A. O., Catala-Lehnen, P., Thomas, P. M., Priemel, M., Rueger, J. M., Nasonkin, I., Bradley, A., Hughes, M. R., Ordonez, N., Cote, G. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214218 · Cited by 209
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
Dacquin, R., Davey, R. A., Laplace, C., Levasseur, R., Morris, H. A., Goldring, S. R., Gebre-Medhin, S., Galson, D. L., Zajac, J. D., & Karsenty, G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312135 · Cited by 206 · cited 6×
“An amylin knockout model resulted in decreased BMD,((54)) an effect that seemed to be mediated through an inhibition of osteoclastogenesis with no apparent effect on osteoblast differentiation or function.”
BackgroundInfluentialEffects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development
Cornish, J., Callon, K. E., Bava, U., Kamona, S. A., Cooper, G. J. S., & Reid, I. R. (2001) · Bone · doi:10.1016/s8756-3282(01)00494-x · Cited by 173 · cited 2×
“to stimulate osteoblasts and inhibit osteoclast numbers in vitro.((27,51)) Although pharmacological doses of calcitonin inhibit bone resorption,((25,68)) it is unclear whether feeding results in a postprandial increase in calcitonin secretion in either rats or humans.”
BackgroundSlowing of Pulsatile Luteinizing Hormone Secretion in Men after Forty-Eight Hours of Fasting
CAMERON, J. L., WELTZIN, T. E., McCONAHA, C., HELMREICH, D. L., & KAYE, W. H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-35 · Cited by 165
Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease.
Taranta, A., Fortunati, D., Longo, M., Rucci, N., Iacomino, E., Aliberti, F., Facciuto, E., Migliaccio, S., Bardella, M. T., Dubini, A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040319 · Cited by 118
Cornish, J., Callon, K. E., King, A. R., Cooper, G. J. S., & Reid, I. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e694 · Cited by 102 · cited 2×
“Pharmacological doses of GIP, GLP 2, amylin, and leptin have been shown to regulate bone turnover in vitro((26,50,51)) and in vivo.((7,31,33,34)) Both in vitro and in vivo studies suggest there is an acute, reversible decrease in bone resorption in response to GLP 2.”
BackgroundTse, T. F., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110967 · Cited by 73 · cited 3×
“The time-course of change and specificity of response to glucose suggest that adrenaline (Ad), noradrenaline (NA), and growth hormone (GH)((23,35)) are unlikely to mediate the acute nutrient-induced decrease in bone resorption, which is first apparent 20 minutes postprandial.”
BackgroundTse, T. F., Clutter, W. E., Shah, S. D., Miller, J. P., & Cryer, P. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110966 · Cited by 68 · cited 4×
“The time-course of change and specificity of response to glucose suggest that adrenaline (Ad), noradrenaline (NA), and growth hormone (GH)((23,35)) are unlikely to mediate the acute nutrient-induced decrease in bone resorption, which is first apparent 20 minutes postprandial.”
BackgroundInfluentialDissociation of the effects of amylin on osteoblast proliferation and bone resorption
Cornish, J., Callon, K. E., Lin, C. Q.-X., Xiao, C. L., Mulvey, T. B., Coy, D. H., Cooper, G. J. S., & Reid, I. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.5.e827 · Cited by 54
Systemic administration of a novel octapeptide, amylin-(1—8), increases bone volume in male mice
Cornish, J., Callon, K. E., Gasser, J. A., Bava, U., Gardiner, E. M., Coy, D. H., Cooper, G. J. S., & Reid, I. R. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e730 · Cited by 38
Cited by
Osteoporosis in Patients With Diabetes Mellitus
Hofbauer, L. C., Brueck, C. C., Singh, S. K., & Dobnig, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070510 · Cited by 503
Bone Metabolism in Obesity and Weight Loss
Shapses, S. A., & Sukumar, D. (2012) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104655 · Cited by 346
Ma, X., Meng, J., Jia, M., Bi, L., Zhou, Y., Wang, Y., Hu, J., He, G., & Luo, X. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1898 · Cited by 200
“Patients on long‐term parenteral feeding displayed a reduced bone mass, which suggested that a deficit in those hormones responding to nutrient ingestion affected bone turnover.((7,8)) Among gastrointestinal hormones, glucagon‐like peptide‐1 (GLP‐1) is an important one that is well known to play crucial roles in blood…”
BackgroundGlucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass
Xie, D., Zhong, Q., Ding, K.-H., Cheng, H., Williams, S., Correa, D., Bollag, W. B., Bollag, R. J., Insogna, K., Troiano, N., et al. (2007) · Bone · doi:10.1016/j.bone.2007.01.007 · Cited by 144
Kim, J.-Y., Lee, S.-K., Jo, K.-J., Song, D.-Y., Lim, D.-M., Park, K.-Y., Bonewald, L. F., & Kim, B.-J. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.01.001 · Cited by 137
Metadata
- Authors
- Clowes, J. A., Khosla, S., & Eastell, R.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 20
- Issue
- 9
- Pages
- 1497-1506
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1995766321
- Cited by
- 87
- References
- 13
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.